Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase III Double Blinded Study of Early Intervention After RADICAl ProstaTEctomy With Androgen Deprivation Therapy With or Without Darolutamide vs. Placebo in Men at Highest Risk of Prostate Cancer Metastasis by Genomic Stratification (ERADICATE)
Principal Investigator
Related Studies
Genomic Health Oncotype DX AR-V7
Investigators: Brian K. Kim, M.D, David S Yee, M.D., MPH, Sivakumar Reddy, M.D., Kristie A. Bobolis, M.D., Nitin Rohatgi, MD, Vijay Suhag, M.D., Rajeswari Chellappah, M.D., Kristin N. Arreola, M.D.